Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
Namita Thapar
Namita Thapar's Investment Grows 38,200% As Emcure Pharma Lists At 31% Premium On NSE
Emcure Pharmaceuticals' stock listing on NSE at 31% premium has resulted in a huge growth of Namita Thapar's investment from ₹ 2.19 crore to ₹ 653 crore.
Chart: Has Shark Tank India Broken Its Promises? Ashneer Grover Says He Hasn't
Fewer Than 50% Of Successful Shark Tank India Season 1 Startups Have Got Funding So Far
Namita Thapar's Investment Grows 38,200% As Emcure Pharma Lists At 31% Premium On NSE
Chart: Has Shark Tank India Broken Its Promises? Ashneer Grover Says He Hasn't
Fewer Than 50% Of Successful Shark Tank India Season 1 Startups Have Got Funding So Far
Over ₹100 Crore Poured Into Startups By Shark Tank India: Report
|
The Indian adaptation of the business reality show, Shark Tank India, has seen over ₹100 crore of investments across its first two seasons, as per a Redseer report. According to the report, 27 startups that appeared on the show secured deals six times greater in value from outside investors within a span of 1.5 years.
